Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review (Olivia Putri Chairunnisa, Mia Audina, & Irawati , Trans.). (2025). The Indonesian Journal of General Medicine, 12(3), 1-48. https://doi.org/10.70070/vbsedq58